NeuroSense Therapeutics Ltd. Travel and Entertainment Expense
NeuroSense Therapeutics Ltd. (NRSN) reported Travel and Entertainment Expense of $219.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:TravelAndEntertainmentExpense · last filed 2026-03-31
| Period end | Travel and Entertainment Expense 12 month |
|---|---|
| 2025-12-31 | $219.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $134.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $164.00K 20-F · filed 2026-03-31 |
| 2022-12-31 | $165.00K 20-F · filed 2025-04-07 |